Author Archives: Sonia Canzater

05.05.17

Louisiana Proposes that the Federal Government Bypass Patent Restrictions to Acquire Cheaper Hepatitis C Drugs

By | Leave a Comment

Anyone who follows U.S. public health issues – or who reads my blog posts – knows that the cost of the drugs needed to treat Hepatitis C infections is very high. The cost of these drugs is of particular concern to state health authorities who are charged with providing health care for Medicaid recipients and […]

Posted in FDA, Healthcare, uncategorized ; Tagged: .

03.10.17

COLLATERAL DAMAGE: REPEALING OBAMACARE WOULD ELIMINATE FUNDING FOR CRITICAL CDC PREVENTION PROGRAMS

By | Leave a Comment

There are many reasons for concern regarding the repercussions of a repeal of the Affordable Care Act, also known as Obamacare. Much of the focus as of late has been on the effect repeal would have on Medicaid recipients and how the cost of health insurance would change under a new plan. However, there are […]

Posted in Health reform, Healthcare, uncategorized ; Tagged: , , , , .

02.07.17

Face the Facts: The benefit of continued support of stem cell research transcends partisan politics.

By | Leave a Comment

Stem cell research is a volatile scientific topic in the US, with supporters who are usually divided along political lines. Conservatives tend to view stem cell research – and particularly embryonic stem cell research – with disfavor. Thus, the new administration poses a threat to the continued support of research and innovation in this field, […]

Posted in Health reform, Healthcare ; Tagged: .

12.22.16

Obama signs $6.3 billion Cures Act – But Does it Do More Harm than Good?

By | Leave a Comment

On December 13th, President Obama signed the 21st Century Cures Act into law. This law provides $6.3 billion for cancer cure research, and to address the growing opioid drug abuse epidemic. The Act also allows for a more streamlined approval process for the FDA to bring new drugs and medical devices to the market. While […]

Posted in FDA, Health reform, uncategorized ; Tagged: , .

11.21.16

Now What?? The Potential Effects of a Trump Administration and Republican-Controlled Congress on Hepatitis C care

By | Leave a Comment

The 2016 presidential election ended in a result that few who are passionate about public health, human rights, and race, gender and sexual orientation equality could have ever wanted. However, as we face the reality of this reality, we who work to improve health outcomes must steel our resolve and continue to address the critical […]

Posted in Health reform, Healthcare ; Tagged: , .

10.26.16

GET YOUR FLU SHOT, OR WE ALL PAY THE PRICE! Unvaccinated adults are a costly economic burden every year in the U.S.

By | Leave a Comment

    Many of us have seen the signs at work, gotten the emails from our health care insurer, or heard the ads on the radio telling us that it is flu season, and thus time to get an annual flu shot.  Many Americans will comply with this yearly health edict, but many will challenge medical wisdom […]

Posted in Global Health, Healthcare, uncategorized ; Tagged: , , , .

09.29.16

O'Neill Institute Hosts Meeting to discuss improving Hepatitis C data collection and surveillance

By | Leave a Comment

On September 19th, the Hepatitis C Policy Project hosted a meeting at the Georgetown University Law Center in Washington, DC to discuss strategies to improve data collection and case surveillance for Hepatitis C in the United States. Thought leaders from a range of public health backgrounds, – including physicians, patient advocates, researchers and federal agency directors […]

Posted in Healthcare, uncategorized ; Tagged: , .

09.29.16

O’Neill Institute Hosts Meeting to discuss improving Hepatitis C data collection and surveillance

By | Leave a Comment

On September 19th, the Hepatitis C Policy Project hosted a meeting at the Georgetown University Law Center in Washington, DC to discuss strategies to improve data collection and case surveillance for Hepatitis C in the United States. Thought leaders from a range of public health backgrounds, – including physicians, patient advocates, researchers and federal agency directors […]

Posted in Healthcare, uncategorized ; Tagged: , .

08.08.16

Spike in hepatitis C rates in young women further supports the need for screenings for all pregnant women

By | Leave a Comment

As the rate of Hepatitis C infections among young Americans increases, so does the risk of infections in infants. The CDC reports a 22% increase between 2011 and 2014  in HCV infections in women of childbearing age, between 15-44 years.  There was also a 14% increase in infections in children 2 years and younger seen during […]

Posted in Health reform, Healthcare, uncategorized ;

07.08.16

Viral Hepatitis is the seventh leading cause of death worldwide: Yet U.S. treatment interventions continue to go underfunded

By | Leave a Comment

An article published on July 6, 2016 in The Lancet ranks viral hepatitis infections – specifically both Hepatitis B (HBV) and Hepatitis C (HCV) – as the seventh leading cause of death worldwide in 2013, up from tenth in 1990. Where other infectious diseases such as tuberculosis, malaria and diarrheal diseases saw sharp declines over this timespan, HBV […]

Posted in Global Health, Health reform, uncategorized ;

Stay Informed

Signup for our mailing list and stay up to date on the latest happenings at The O’Neill Institute

Or sign up for our RSS Feed

The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.